"Amiodarone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
| Descriptor ID |
D000638
|
| MeSH Number(s) |
D03.633.100.127.075
|
| Concept/Terms |
Cordarone- Cordarone
- Amiodarex
- Trangorex
- Kordaron
- Cordarex
|
Below are MeSH descriptors whose meaning is more general than "Amiodarone".
Below are MeSH descriptors whose meaning is more specific than "Amiodarone".
This graph shows the total number of publications written about "Amiodarone" by people in this website by year, and whether "Amiodarone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amiodarone" by people in Profiles.
-
Safety and Efficacy of Prophylactic Amiodarone After Left Ventricular Assist Device. ASAIO J. 2023 01 01; 69(1):96-100.
-
Calcium-Induced Autonomic Denervation in Patients With Post-Operative Atrial Fibrillation. J Am Coll Cardiol. 2021 01 05; 77(1):57-67.
-
Management of amiodarone extravasation with intradermal hyaluronidase. Am J Health Syst Pharm. 2017 Oct 01; 74(19):1545-1548.
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Jan; 8(1):157-76.
-
Images in clinical medicine. Amiodarone-induced skin discoloration. N Engl J Med. 1997 Dec 18; 337(25):1813.
-
Amiodarone causes acute oxidant lung injury in ventilated and perfused rabbit lungs. J Cardiovasc Pharmacol. 1988 Jul; 12(1):23-36.
-
Cumulative effects of amiodarone on inducibility of ventricular tachycardia: implications for electrophysiological testing. Pacing Clin Electrophysiol. 1988 Apr; 11(4):434-44.
-
Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome. Am Heart J. 1987 Dec; 114(6):1436-44.
-
Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms. Am Heart J. 1982 Feb; 103(2):177-84.
-
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med. 1981 Sep 03; 305(10):539-45.